Some further consideration on the role of oral contraceptives in breast carcinogenesis

C. La Vecchia, P. Bruzzi, P. Boyle

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Available evidence concerning oral contraceptives and their potential interaction with reproductive history on breast cancer risk is reviewed. The relative risks in 15 out of 15 studies were above unity among younger women (i.e., below age 35 and perhaps up to 45) for long-term oral contraceptive use, although apparent heterogeneities emerged in the risk estimates. The overall evidence is reassuring in subsequent age groups, whereas the modifying effects or interactions between oral contraceptives, reproductive factors and breast cancer risk are still largely undefined. Thus we suggest that, besides chance and bias, the apparent discrepancies between various studies should be considered within the framework of the complex time- and age-effects of hormone-related risk factors on breast carcinogenesis.

Original languageEnglish
Pages (from-to)220-224
Number of pages5
JournalTumori
Volume76
Issue number3
Publication statusPublished - 1990

Fingerprint

Oral Contraceptives
Carcinogenesis
Breast
Breast Neoplasms
Reproductive History
Age Groups
Hormones

ASJC Scopus subject areas

  • Cancer Research

Cite this

Some further consideration on the role of oral contraceptives in breast carcinogenesis. / La Vecchia, C.; Bruzzi, P.; Boyle, P.

In: Tumori, Vol. 76, No. 3, 1990, p. 220-224.

Research output: Contribution to journalArticle

La Vecchia, C. ; Bruzzi, P. ; Boyle, P. / Some further consideration on the role of oral contraceptives in breast carcinogenesis. In: Tumori. 1990 ; Vol. 76, No. 3. pp. 220-224.
@article{1293e596229e492893713729f60fab3a,
title = "Some further consideration on the role of oral contraceptives in breast carcinogenesis",
abstract = "Available evidence concerning oral contraceptives and their potential interaction with reproductive history on breast cancer risk is reviewed. The relative risks in 15 out of 15 studies were above unity among younger women (i.e., below age 35 and perhaps up to 45) for long-term oral contraceptive use, although apparent heterogeneities emerged in the risk estimates. The overall evidence is reassuring in subsequent age groups, whereas the modifying effects or interactions between oral contraceptives, reproductive factors and breast cancer risk are still largely undefined. Thus we suggest that, besides chance and bias, the apparent discrepancies between various studies should be considered within the framework of the complex time- and age-effects of hormone-related risk factors on breast carcinogenesis.",
author = "{La Vecchia}, C. and P. Bruzzi and P. Boyle",
year = "1990",
language = "English",
volume = "76",
pages = "220--224",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "3",

}

TY - JOUR

T1 - Some further consideration on the role of oral contraceptives in breast carcinogenesis

AU - La Vecchia, C.

AU - Bruzzi, P.

AU - Boyle, P.

PY - 1990

Y1 - 1990

N2 - Available evidence concerning oral contraceptives and their potential interaction with reproductive history on breast cancer risk is reviewed. The relative risks in 15 out of 15 studies were above unity among younger women (i.e., below age 35 and perhaps up to 45) for long-term oral contraceptive use, although apparent heterogeneities emerged in the risk estimates. The overall evidence is reassuring in subsequent age groups, whereas the modifying effects or interactions between oral contraceptives, reproductive factors and breast cancer risk are still largely undefined. Thus we suggest that, besides chance and bias, the apparent discrepancies between various studies should be considered within the framework of the complex time- and age-effects of hormone-related risk factors on breast carcinogenesis.

AB - Available evidence concerning oral contraceptives and their potential interaction with reproductive history on breast cancer risk is reviewed. The relative risks in 15 out of 15 studies were above unity among younger women (i.e., below age 35 and perhaps up to 45) for long-term oral contraceptive use, although apparent heterogeneities emerged in the risk estimates. The overall evidence is reassuring in subsequent age groups, whereas the modifying effects or interactions between oral contraceptives, reproductive factors and breast cancer risk are still largely undefined. Thus we suggest that, besides chance and bias, the apparent discrepancies between various studies should be considered within the framework of the complex time- and age-effects of hormone-related risk factors on breast carcinogenesis.

UR - http://www.scopus.com/inward/record.url?scp=0025087081&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025087081&partnerID=8YFLogxK

M3 - Article

VL - 76

SP - 220

EP - 224

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 3

ER -